I-953

TREATMENT OF ADULT PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE CHRONICMYELOID LEUKEMIA (PH+ CML) IN CHRONIC PHASE (CP)